{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:32:28Z","timestamp":1784043148793,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2022R1F1A1071409"],"award-info":[{"award-number":["NRF-2022R1F1A1071409"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11730-x","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T08:10:20Z","timestamp":1749111020000},"page":"7549-7559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of the LI-RADS radiation treatment response assessment v2024 in comparison with the modified RECIST"],"prefix":"10.1007","volume":"35","author":[{"given":"Hokun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1157-415X","authenticated-orcid":false,"given":"Bohyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Hyun","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Won","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil Soo","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Il","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Suk","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jong","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"11730_CR1","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M et al (2023) AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 78:1922\u20131965","journal-title":"Hepatology"},{"key":"11730_CR2","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver (2024) EASL clinical practice guidelines on the management of hepatocellular carcinoma. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.028","DOI":"10.1016\/j.jhep.2024.08.028"},{"key":"11730_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J et al (2022) BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol 76:681\u2013693","journal-title":"J Hepatol"},{"key":"11730_CR4","unstructured":"National Comprehensive Cancer Network (2023) Hepatocellular carcinoma (version 2.2023). Available via https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1514"},{"key":"11730_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","volume":"18","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, De Baere T, Kulik L et al (2021) Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 18:293\u2013313","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11730_CR6","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/hep.31819","volume":"74","author":"R Salem","year":"2021","unstructured":"Salem R, Johnson GE, Kim E et al (2021) Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study. Hepatology 74:2342\u20132352","journal-title":"Hepatology"},{"key":"11730_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.17998\/jlc.2024.02.26","volume":"24","author":"D Kim","year":"2024","unstructured":"Kim D, Kim JS (2024) Current perspectives on radiotherapy in hepatocellular carcinoma management: a comprehensive review. J Liver Cancer 24:33\u201346","journal-title":"J Liver Cancer"},{"key":"11730_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","volume":"34","author":"DR Wahl","year":"2016","unstructured":"Wahl DR, Stenmark MH, Tao Y et al (2016) Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma. J Clin Oncol 34:452\u2013459","journal-title":"J Clin Oncol"},{"key":"11730_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.annonc.2021.02.014","volume":"32","author":"A Vogel","year":"2021","unstructured":"Vogel A, Martinelli E, clinicalguidelines@esmo.org EGCEa, Committee EG (2021) Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO clinical practice guidelines. Ann Oncol 32:801\u2013805","journal-title":"Ann Oncol"},{"key":"11730_CR10","doi-asserted-by":"crossref","unstructured":"Martin M, Aslam A, Mubarak E et al (2023) Imaging after liver-directed therapy: evidenced-based update of the LI-RADS treatment response algorithm. Hepatoma Res 9:21","DOI":"10.20517\/2394-5079.2022.95"},{"key":"11730_CR11","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232408","volume":"313","author":"A Aslam","year":"2024","unstructured":"Aslam A, Chernyak V, Miller FH et al (2024) CT\/MRI LI-RADS 2024 update: treatment response assessment. Radiology 313:e232408","journal-title":"Radiology"},{"key":"11730_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13244-019-0801-z","volume":"10","author":"N Voizard","year":"2019","unstructured":"Voizard N, Cerny M, Assad A et al (2019) Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review. Insights Imaging 10:121","journal-title":"Insights Imaging"},{"key":"11730_CR13","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.ijrobp.2017.08.022","volume":"102","author":"M Mendiratta-Lala","year":"2018","unstructured":"Mendiratta-Lala M, Gu E, Owen D et al (2018) Imaging findings within the first 12 months of hepatocellular carcinoma treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 102:1063\u20131069","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11730_CR14","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1007\/s00261-020-02532-4","volume":"45","author":"M Mendiratta-Lala","year":"2020","unstructured":"Mendiratta-Lala M, Masch W, Owen D et al (2020) Natural history of hepatocellular carcinoma after stereotactic body radiation therapy. Abdom Radiol (NY) 45:3698\u20133708","journal-title":"Abdom Radiol (NY)"},{"key":"11730_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52\u201360","journal-title":"Semin Liver Dis"},{"key":"11730_CR16","unstructured":"American College of Radiology (2018) CT\/MRI LI-RADS\u00ae v2018. Available via https:\/\/www.acr.org\/Clinical-Resources\/Reporting-and-Data-Systems\/LI-RADS\/CT-MRI-LI-RADS-v2018"},{"key":"11730_CR17","unstructured":"American College of Radiology (2024) Radiation CT\/MRI LI-RADS\u00ae TRA v2024. Available via https:\/\/www.acr.org\/-\/media\/ACR\/Files\/RADS\/LI-RADS\/LI-RADS-CTMR-Radiation-TRA-v2024-Core.pdf"},{"key":"11730_CR18","first-page":"100465","volume":"39","author":"QQ Wu","year":"2023","unstructured":"Wu QQ, Chen YX, Du SS, Hu Y, Yang P, Zeng ZC (2023) Early complete tumor response as a survival predictor in hepatocellular carcinoma patients receiving stereotactic body radiation therapy. Clin Transl Radiat Oncol 39:100465","journal-title":"Clin Transl Radiat Oncol"},{"key":"11730_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijrobp.2018.09.004","volume":"103","author":"M Mendiratta-Lala","year":"2019","unstructured":"Mendiratta-Lala M, Masch W, Shankar PR et al (2019) Magnetic resonance imaging evaluation of hepatocellular carcinoma treated with stereotactic body radiation therapy: long term imaging follow-up. Int J Radiat Oncol Biol Phys 103:169\u2013179","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11730_CR20","doi-asserted-by":"publisher","first-page":"W812","DOI":"10.2214\/AJR.12.10169","volume":"201","author":"N Sanuki","year":"2013","unstructured":"Sanuki N, Takeda A, Mizuno T et al (2013) Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis. AJR Am J Roentgenol 201:W812\u2013W820","journal-title":"AJR Am J Roentgenol"},{"key":"11730_CR21","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00261-023-03827-y","volume":"48","author":"Z Mai","year":"2023","unstructured":"Mai Z, Yang Q, Xu J et al (2023) Response evaluation of hepatocellular carcinoma treated with stereotactic body radiation therapy: magnetic resonance imaging findings. Abdom Radiol (NY) 48:1995\u20132007","journal-title":"Abdom Radiol (NY)"},{"key":"11730_CR22","doi-asserted-by":"crossref","unstructured":"Jiao Y, Cao F, Liu H (2022) Radiation-induced cell death and its mechanisms. Health Phys 123:376\u2013386","DOI":"10.1097\/HP.0000000000001601"},{"key":"11730_CR23","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3348\/kjr.2020.1159","volume":"22","author":"J Yoon","year":"2021","unstructured":"Yoon J, Lee S, Shin J, Kim SS, Kim GM, Won JY (2021) LI-RADS version 2018 treatment response algorithm: diagnostic performance after transarterial radioembolization for hepatocellular carcinoma. Korean J Radiol 22:1279\u20131288","journal-title":"Korean J Radiol"},{"key":"11730_CR24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ijrobp.2021.10.006","volume":"112","author":"M Mendiratta-Lala","year":"2022","unstructured":"Mendiratta-Lala M, Aslam A, Maturen KE et al (2022) LI-RADS treatment response algorithm: performance and diagnostic accuracy with radiologic-pathologic explant correlation in patients with sbrt-treated hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 112:704\u2013714","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11730_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.5009\/gnl19197","volume":"14","author":"JS Lee","year":"2020","unstructured":"Lee JS, Choi HJ, Kim BK et al (2020) The modified response evaluation criteria in solid tumors (RECIST) yield a more accurate prognoses than the RECIST 1.1 in hepatocellular carcinoma treated with transarterial radioembolization. Gut Liver 14:765\u2013774","journal-title":"Gut Liver"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11730-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11730-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11730-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:44:31Z","timestamp":1763639071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11730-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11730"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11730-x","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Bohyun Kim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the IRB.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"IRB approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No overlap in study subjects.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}